id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1736-0065,FDA,FDA-2020-N-1736,"Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: 
A Risk Management Tool for Antimicrobial New Animal Drugs; Reopening of the Comment Period",Notice,Request for Comments,2021-04-12T04:00:00Z,2021,4,2021-04-12T04:00:00Z,2021-04-23T03:59:59Z,2021-07-23T01:00:54Z,2021-07452,0,0,0900006484aa3672
FDA-2020-N-1736-0018,FDA,FDA-2020-N-1736,Public meeting transcript 1.5.21,Other,Transcript(s),2021-01-06T05:00:00Z,2021,1,2021-01-06T05:00:00Z,,2021-01-06T16:06:39Z,,0,0,09000064849e0df1
FDA-2020-N-1736-0017,FDA,FDA-2020-N-1736,Public Meeting Slides,Other,Meeting Exhibits,2021-01-06T05:00:00Z,2021,1,2021-01-06T05:00:00Z,,2021-01-06T16:05:17Z,,0,0,09000064849e0df0